• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与触角足肽融合的polo样激酶1的polo盒的有效内化导致癌细胞增殖受到抑制。

Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation.

作者信息

Yuan Juping, Krämer Andrea, Eckerdt Frank, Kaufmann Manfred, Strebhardt Klaus

机构信息

Department of Obstetrics and Gynecology, Medical School, J.W. Goethe-University, 60590 Frankfurt, Germany.

出版信息

Cancer Res. 2002 Aug 1;62(15):4186-90.

PMID:12154015
Abstract

Polo-like kinases (Plk) regulate multiple stages in mitosis. Plk1 is overexpressed in tumors. The COOH-terminal regions of Plks contain a conserved domain, termed polo-box, which is required for subcellular localization and for physical interaction with substrates. We linked the polo-box (amino acids 410-429) of Plk1 to an Antennapedia peptide and studied its impact on tumor cells. Whereas the wild-type polo-box inhibited the proliferation of tumor cells associated with induction of apoptosis, a mutated derivative was much less effective. The treatment caused mitotic arrest, misaligned chromosomes, and multiple centrosomes. Taken together, membrane-permeable polo-box peptides inhibit cancer cell proliferation efficiently.

摘要

Polo样激酶(Plk)调节有丝分裂的多个阶段。Plk1在肿瘤中过表达。Plk的COOH末端区域包含一个保守结构域,称为polo框,它是亚细胞定位和与底物物理相互作用所必需的。我们将Plk1的polo框(氨基酸410 - 429)与触角足肽连接,并研究了其对肿瘤细胞的影响。野生型polo框抑制与凋亡诱导相关的肿瘤细胞增殖,而突变衍生物的效果则要差得多。该处理导致有丝分裂停滞、染色体排列不齐和多个中心体。综上所述,可透过细胞膜的polo框肽能有效抑制癌细胞增殖。

相似文献

1
Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation.与触角足肽融合的polo样激酶1的polo盒的有效内化导致癌细胞增殖受到抑制。
Cancer Res. 2002 Aug 1;62(15):4186-90.
2
Polo-box motif targets a centrosome regulator, RanGTPase.Polo-box基序靶向一种中心体调节因子——RanGTP酶。
Biochem Biophys Res Commun. 2004 Dec 3;325(1):257-64. doi: 10.1016/j.bbrc.2004.10.023.
3
Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.与内化序列融合的c-Myc螺旋1型肽对癌细胞生长和c-Myc转录活性的抑制作用。
Cancer Res. 1998 Aug 15;58(16):3654-9.
4
The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization.Sak马球盒包含一个足以实现有丝分裂亚细胞定位的结构域。
Nat Struct Biol. 2002 Oct;9(10):719-24. doi: 10.1038/nsb848.
5
Getting in and out of mitosis with Polo-like kinase-1.通过Polo样激酶-1进出有丝分裂
Oncogene. 2005 Apr 18;24(17):2844-59. doi: 10.1038/sj.onc.1208617.
6
Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.反义寡核苷酸下调人polo样激酶活性可诱导癌细胞生长抑制。
Oncogene. 2002 May 9;21(20):3162-71. doi: 10.1038/sj.onc.1205412.
7
In vivo tumor imaging using polo-box domain of polo-like kinase 1 targeted peptide.利用 polo 样激酶 1 靶向肽的 polo 框域进行体内肿瘤成像。
Biomaterials. 2012 Oct;33(29):6915-25. doi: 10.1016/j.biomaterials.2012.06.046. Epub 2012 Jul 15.
8
Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis.polo样激酶1特异性抑制剂GSK461364A具有明显的浓度依赖性效应,包括对细胞凋亡的不同影响。
Cancer Res. 2009 Sep 1;69(17):6969-77. doi: 10.1158/0008-5472.CAN-09-0945. Epub 2009 Aug 18.
9
Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores.Polo样激酶1产生张力感应3F3/2磷酸表位并调节动粒处纺锤体检查点蛋白的结合。
Curr Biol. 2005 Jun 21;15(12):1078-89. doi: 10.1016/j.cub.2005.05.026.
10
Molecular interactions of Polo-like-kinase 1 with the mitotic kinesin-like protein CHO1/MKLP-1.Polo样激酶1与有丝分裂驱动蛋白样蛋白CHO1/MKLP-1的分子相互作用。
J Cell Sci. 2004 Jul 1;117(Pt 15):3233-46. doi: 10.1242/jcs.01173. Epub 2004 Jun 15.

引用本文的文献

1
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer.截短的DAPK变体可恢复肿瘤抑制活性,并在高级别浆液性卵巢癌中与标准疗法协同作用。
Cancers (Basel). 2025 Jun 8;17(12):1910. doi: 10.3390/cancers17121910.
2
Structure-activity and mechanistic studies of non-peptidic inhibitors of the PLK1 polo box domain identified through REPLACE.通过 REPLACE 鉴定的非肽类 PLK1 极性盒结构域抑制剂的结构-活性和作用机制研究。
Eur J Med Chem. 2022 Jan 5;227:113926. doi: 10.1016/j.ejmech.2021.113926. Epub 2021 Oct 21.
3
Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8.
CD95的配体刺激诱导Plk3激活,随后caspase-8发生磷酸化。
Cell Res. 2016 Aug;26(8):914-34. doi: 10.1038/cr.2016.78. Epub 2016 Jun 21.
4
RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation.由SLAMF3表达介导的RB/PLK1依赖性诱导途径抑制有丝分裂并控制肝癌细胞增殖。
Oncotarget. 2016 Mar 1;7(9):9832-43. doi: 10.18632/oncotarget.6954.
5
Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.癌症治疗药物向细胞外和细胞内靶点的递送:决定因素、障碍、挑战与机遇。
Adv Drug Deliv Rev. 2016 Feb 1;97:280-301. doi: 10.1016/j.addr.2015.12.002. Epub 2015 Dec 11.
6
The role of Plk3 in oncogenesis.Plk3 在肿瘤发生中的作用。
Oncogene. 2016 Jan 14;35(2):135-47. doi: 10.1038/onc.2015.105. Epub 2015 Apr 27.
7
Structural analysis of the polo-box domain of human Polo-like kinase 2.人类Polo样激酶2的Polo盒结构域的结构分析
Proteins. 2015 Jul;83(7):1201-8. doi: 10.1002/prot.24804. Epub 2015 Apr 28.
8
Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy.永恒对手之间的较量:恢复功能性p53并抑制Polo样激酶1作为癌症治疗方法
Oncotarget. 2013 Jul;4(7):958-71. doi: 10.18632/oncotarget.1096.
9
Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.Polo-box 结构域抑制剂 Poloxin 激活纺锤体组装检查点并抑制体内肿瘤生长。
Am J Pathol. 2011 Oct;179(4):2091-9. doi: 10.1016/j.ajpath.2011.06.031. Epub 2011 Aug 10.
10
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.纳米药物向实体瘤细胞外和细胞内区室的递送。
Adv Drug Deliv Rev. 2012 Jan;64(1):29-39. doi: 10.1016/j.addr.2011.04.006. Epub 2011 May 3.